Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

Everolimus, when combined with exemestane, adds...

Journal article

Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer

Authors

Tannock IF; Pond GR

Journal

Annals of Oncology, Vol. 25, No. 10,

Publisher

Elsevier

Publication Date

October 2014

DOI

10.1093/annonc/mdu371

ISSN

0923-7534

Associated Experts

Gregory Pond

Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis 3202 Clinical sciences

Medical Subject Headings (MeSH)

Breast Neoplasms Drug-Related Side Effects and Adverse Reactions Female Humans Sirolimus

View published work (Non-McMaster Users)

View published work (McMaster Users)